Arnaud John Kombe Kombe

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics.
  2022 L1 75/100

1 assessed by us (1 reproduced) · 37 not yet assessed — every PubMed paper on record, linked below.

• A Tripartite Model for EBV‐Driven Multiple Sclerosis: B Cell Survival, Altered Self‐Presentation, and HLA‐DR15‐Restricted T Cell Cross‐Reactivity ↗

  iNew Medicine · 2026
  not yet assessed
• Ex vivo modeling of nasal epithelial airway inflammation in respiratory viral infections ↗

  Frontiers in Microbiology · 2026 · PMID 42317753
  not yet assessed
• Data Sheet 1_Ex vivo modeling of nasal epithelial airway inflammation in respiratory viral infections.pdf ↗

  Figshare · 2026
  not yet assessed
• Overview of methods that determine mitochondrial function in human disease ↗

  Metabolism · 2025 · PMID 40389059
  not yet assessed
• HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection? ↗

  Metabolism · 2025 · PMID 41238103
  not yet assessed
• NLRP inflammasomes in health and disease ↗

  Molecular Biomedicine · 2024 · PMID 38644450
  not yet assessed
• The Role of Inflammation in the Pathogenesis of Viral Respiratory Infections ↗

  Microorganisms · 2024 · PMID 39770727
  not yet assessed
• The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections ↗

  International Journal of Molecular Sciences · 2024 · PMID 39000157
  not yet assessed
• Immunoglobulin A response to SARS-CoV-2 infection and immunity ↗

  Heliyon · 2024 · PMID 38230244
  not yet assessed
• SARS-CoV-2 replication and drug discovery ↗

  Molecular and Cellular Probes · 2024 · PMID 39025272
  not yet assessed
• PRMT1 and TDRD3 promote stress granule assembly by rebuilding the protein-RNA interaction network ↗

  International Journal of Biological Macromolecules · 2024 · PMID 39097054
  not yet assessed
• Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants ↗

  Journal of Biological Chemistry · 2024 · PMID 39002680
  not yet assessed
• The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory Infections ↗

  Pathogens · 2023 · PMID 38251346
  not yet assessed
• Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis ↗

  Frontiers in Bioscience-Landmark · 2023 · PMID 37919078
  not yet assessed
• Human papillomavirus infections and cervical cancer ↗

  Elsevier eBooks · 2023
  not yet assessed
• List of contributors ↗

  Elsevier eBooks · 2023
  not yet assessed
• Editorial: Host-microbe interaction in SARS-CoV-2 infection: mechanism and intervention ↗

  Frontiers in Immunology · 2023 · PMID 37143671
  not yet assessed
• Immunoglobulin a Response to Sars-Cov-2 Infection and Immunity ↗

  SSRN Electronic Journal · 2023
  not yet assessed
• Review of: "[Commentary] Implications of HPV infectivity in early diagnosis and treatment of advanced/recurrent malignancies" ↗

  2023
  not yet assessed
• Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics

  Frontiers in Microbiology · 2022 · PMID 35983322
  L1 75/100
• CD8+ T-cell immune escape by SARS-CoV-2 variants of concern ↗

  Frontiers in Immunology · 2022 · PMID 36389664
  not yet assessed
• Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review ↗

  Clinical & Translational Oncology · 2022 · PMID 35913663
  not yet assessed
• Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis ↗

  Pathogens · 2022 · PMID 35056014
  not yet assessed
• Immune Evasion by the Highly Mutated SARS-CoV-2 Omicron Variant ↗

  Infection and Drug Resistance · 2022
  not yet assessed
• SARS-CoV-2 nucleocapsid protein: Importance in viral infection ↗

  JUSTC · 2022
  not yet assessed
• Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics ↗

  Frontiers in Microbiology · 2022 · PMID 36338104
  not yet assessed
• Development of a Novel Anti-SARS-CoV-2 Antiviral: Effective Inhibitory Activity of Brilacidin ↗

  Journal of Biomedical Research & Environmental Sciences · 2022
  not yet assessed
• Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation ↗

  Frontiers in Public Health · 2021 · PMID 33553082
  not yet assessed
• Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity ↗

  Seminars in Immunology · 2021 · PMID 34836774
  not yet assessed
• Identification of a Novel Major Allergen in Buckwheat Seeds: Fag t 6 ↗

  Journal of Agricultural and Food Chemistry · 2021 · PMID 34076413
  not yet assessed
• Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection ↗

  Frontiers in Molecular Biosciences · 2021 · PMID 34136533
  not yet assessed
• Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product ↗

  Biochemical and Biophysical Research Communications · 2021 · PMID 34653677
  not yet assessed
• Treatment of Chikungunya Virus (CHIKV) Using Targeted Immunotherapy ↗

  Infectious diseases · 2021
  not yet assessed
• A Low Viral Dose in COVID-19 Patient: A Case Report ↗

  Frontiers in Public Health · 2020 · PMID 32671013
  not yet assessed
• COVID-19 diagnosis and study of serum SARS-CoV-2 specific IgA, IgM and IgG by chemiluminescence immunoanalysis ↗

  medRxiv · 2020
  not yet assessed
• Pharmacological Inhibitors of the NLRP3 Inflammasome ↗

  Frontiers in Immunology · 2019 · PMID 31749805
  not yet assessed
• Structure determination of CAMP factor of Mobiluncus curtisii and insights into structural dynamics ↗

  International Journal of Biological Macromolecules · 2019 · PMID 31739050
  not yet assessed
• Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon ↗

  PLoS ONE · 2018 · PMID 29385148
  not yet assessed